![]() Luminex Luminex is a company that develops and manufactures multiplexing technologies for researchers and clinicians. | ![]() Bardy Diagnostics Bardy Diagnostics is a company manufacturing an ambulatory cardiac patch for remote monitoring. | ||||
Founding Date | Founding Date 1990 | Founding Date 1995 | Founding Date 2010 | Founding Date 2013 | Founding Date 1988 |
Type | Type Subsidiary | Type Subsidiary | Type Subsidiary | Type Private | Type Private |
Tags | |||||
Locations | Locations Salt Lake City, US HQ | Locations Austin, US HQ Toronto, CA Shanghai, CN Hong Kong, HK Saluggia, IT Tokyo, JP 's Hertogenbosch, NL see more | Locations Carlsbad, US HQ Carlsbad, US | Locations Seattle, US HQ Chicago, US Houston, US New Providence, US | Locations HQ |
Employees | Employees 6551% decrease | Employees 1,007 | Employees 4402% increase | Employees 1153% decrease | Employees 2262% increase |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $417.4m (FY, 2020) | Revenue (est.) $171.6m (FY, 2020) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $169.5m (FY, 2020) | Cost of goods $103.6m (FY, 2020) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $247.9m (FY, 2020) | Gross profit $67.9m (FY, 2020) | Gross profit N/A | Gross profit N/A |
Net income | Net income N/A | Net income $15.2m (FY, 2020) | Net income ($18.6m) (FY, 2020) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 70m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 35.5m | Total funding raised N/A |

Luminex is a company that develops and manufactures multiplexing technologies for researchers and clinicians.
View company
GenMark Diagnostics is a provider of multiplex molecular diagnostic solutions.
View company
Bardy Diagnostics is a company manufacturing an ambulatory cardiac patch for remote monitoring.
View company
Alifax is a company providing solutions in clinical diagnostics.
View company